Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin
Clinical trial NCT00329225 · COMPLETED
Trial details
- NCT number
- NCT00329225
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Primary completion
- 2004-04-01
- Enrollment
- 630
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.